Vancouver Frontotemporal Dementia Conference Shows Awakening Field First Data from GENFI1: Brain’s Insula Region Shrinks A Decade Before FTD German Network of 700 FTLD Patients Presents Baseline Data Meet the Artful Leftie: NIH Jump-Starts U.S.-Canadian F
Society for Neuroscience Annual Meeting: A Haven for Basic Science Measuring Rapid Changes in Brain Aβ in Live Mice TREM2 Data Surprise at SfN Annual Meeting Meet GE180: A PET Ligand for Tracking Neuroinflammation? Exosomes: The FedEx of the Nervous Syste
CTAD Shows Alzheimer’s Field Trying to Reinvent Itself Rusty Unleashed: Forget Disease Modification, Go for Big Effect From Shared CAP, Secondary Prevention Trials Are Off and Running Immunotherapy I: Baby Steps, but No Breakthroughs Immunotherapy II: Act
Human Amyloid Imaging Meeting Was Abuzz With Talk of Tau Tau Tracer T807/AV1451 Tracks Neurodegenerative Progression Tau PET Fits With CSF, Grows Over Time, Picks up Frontotemporal Cases What If It’s Not Garden-Variety AD? Telling Variants Apart by Where
Keystone Symposia Meeting, Part 1—Alzheimer’s Disease: Genes, Cellular Pathways and Therapies Keystone Symposia Meeting, Part 2—Genetics and Epidemiology of AD Keystone Symposia Meeting, Part 3—Amyloid Precursor Protein Function Keystone Symposia Meeting,
Neuroinflammation Field Grapples With Complexity at Keystone Symposia Nature Versus Nurture: What Gives Microglia Their Identity? Microglia in Disease: Innocent Bystanders, or Agents of Destruction? United in Confusion: TREM2 Puzzles Researchers in Taos C
Alzheimer’s Disease Research Summit 2015: Three Years In Alzheimer's Disease Research Summit 2015: Expanding the Horizon Research Summit 2015 Recommendations Released The National Institutes of Health hosted a meeting earlier this month as leaders in
Biogen Antibody Buoyed by Phase 1 Data and Hungry Investors Antibody Against α-Synuclein Looks Safe In Phase 1 At AD/PD Meeting, New BACE Inhibitor Struts Its Stuff D-peptides as Drugs? Protein Therapy Approaching Phase 1 Trials New Genetics Frontiers: Fi
Davies, Sperling Share 2015 Potamkin Prize New PET Tracer Tracks Preclinical Movement Disorders Neurodegenerative Proteins in the Skin Could be Diagnostic The 67th American Academy of Neurology conference drew more than 12,000 attendees to Washington, D.C
Massive Mouse Study Bolsters Rationale for Combination Therapy TREM2 Tidbits at AAIC: Genetics, Clinical Data New Data on Autosomal-Dominant Alzheimer’s Point to Early Fissures in the Brain’s Microarchitecture Aducanumab, Solanezumab, Gantenerumab Data Li
100 DIAN Family Members Gather for Their First International Meeting At DIAN Family Meeting, Funding News Caps Talk of Inadequate Services Families Challenge DIAN Scientists to Do Even More, Faster Throughout the five days of the 2015 Alzheimer's Ass
VasCog 2015—Highlights of a Conference Every so often, an intrepid reader steps forward to enlighten the community by organizing notes from a conference that few fellow Alzforum readers got to attend. This week, Donna Wilcock of the University of Kentucky
Snapshots from the Society for Neuroscience Annual Meeting Microglia Control Synapse Number in Multiple Disease States Might Normalizing Brain Development Help in Down’s Syndrome? Potential Parkinson’s Treatments Target α-Synuclein, Cell Replacement Alzhe